Literature DB >> 19837526

Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007).

S Thibaut1, J Caillon, C Huart, G Grandjean, P Lombrail, G Potel, F Ballereau.   

Abstract

BACKGROUND: The aim of this study was to determine the susceptibility of bacterial strains identified in community-acquired infections. Surveillance was made by a network of 32 medical analysis laboratories in the five departments of the French Region "Pays de la Loire".
METHODS: All Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) strains isolated in these laboratories over a 4-year period, from January 2004 to December 2007, were included in the investigation.
RESULTS: Eighty-four thousand and twenty-nine strains were collected: 90.6% of E. coli and 9.4% of S. aureus. E. coli isolates were mainly isolated from urine (97.2%). S. aureus isolates were more frequently isolated from pus (42.30%), from urinary samples (19.53%), or genital tract samples (14.36%). This study confirms the worrying E. coli evolution of resistance to quinolones. Indeed, during the study period, ofloxacin or norfloxacin susceptibility decreased gradually and the susceptibility rate to ciprofloxacin decreased slightly during and after 2006 (94.01% in 2005; 92.81% in 2006, and 91.62% in 2007). One thousand four hundred and thirty-five methicillin-resistant S. aureus (MRSA) strains were isolated. We observed a decrease of resistance to oxacillin: 20.73% in 2004 and 16.65% in 2006 (p<0.01). In 2007, this resistance to oxacillin seemed to increase (18.26%).
CONCLUSIONS: Our data confirms the serious need to monitor transmission of these strains between community and hospitals. A better knowledge of the epidemiological behavior of these BMR will contribute to better-adapted antibiotics strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837526     DOI: 10.1016/j.medmal.2009.01.011

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  6 in total

1.  Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter?

Authors:  O Grignon; E Montassier; S Corvec; D Lepelletier; J-B Hardouin; J Caillon; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-23       Impact factor: 3.267

2.  Evaluation of the French surveillance system for epidemiological surveillance of antimicrobial resistance in the community and nursing homes.

Authors:  Lucie Collineau; Euriel Godebert; Sonia Thibaut; Olivier Lemenand; Gabriel Birgand; Jocelyne Caillon; Clémence Bourely
Journal:  JAC Antimicrob Resist       Date:  2022-07-04

3.  High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries.

Authors:  A Tavares; M Miragaia; J Rolo; C Coelho; H de Lencastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-21       Impact factor: 3.267

4.  Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.

Authors:  E Batard; M-A Vibet; S Thibaut; S Corvec; J Pivette; D Lepelletier; J Caillon; E Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-26       Impact factor: 3.267

Review 5.  Prevalence of antibiotic susceptibility and resistance of Escherichia coli in acute uncomplicated cystitis in Korea: Systematic review and meta-analysis.

Authors:  Jae Heon Kim; Hwa Yeon Sun; Tae Hyong Kim; Sung Ryul Shim; Seung Whan Doo; Won Jae Yang; Eun Jung Lee; Yun Seob Song
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

6.  Fermentation and Storage Characteristics of "Fuji" Apple Juice Using Lactobacillus acidophilus, Lactobacillus casei and Lactobacillus plantarum: Microbial Growth, Metabolism of Bioactives and in vitro Bioactivities.

Authors:  Jie Yang; Yue Sun; Tengqi Gao; Yue Wu; Hao Sun; Qingzheng Zhu; Chunsheng Liu; Chuang Zhou; Yongbin Han; Yang Tao
Journal:  Front Nutr       Date:  2022-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.